Growth foothold IMS operates as a leading national distributor in the alternate site market with flexible rental and purchase options for infusion and respiratory equipment, signaling opportunities to upsell bundled rental programs and long-term lease agreements to hospitals, clinics, and home health providers.

Financial scale Revenue range of 25 to 50 million and a workforce size of 201–500 imply a solid mid-market footprint with potential for expanding high-margin consumables and disposable product lines to existing customers, especially in infusion, respiratory, and enteral feeding segments.

Partnered expansion Strategic partnerships in 2021 with International Medical Industries to enter home health markets suggest receptiveness to distribution collaborations; identify similar alliances to broaden product reach, particularly in secure drug delivery and homecare settings.

Tech-enabled sales Adoption of HubSpot Analytics, Salesforce, Tableau and other platforms indicates a data-driven sales approach. Leverage CRM and analytics to target high-potential accounts, optimize upsell/curchase paths, and forecast demand for infusion and respiratory disposables.

Competitive landscape Operating alongside major players with broad portfolios (Stryker, Zimmer Biomet, Smith+Nephew, etc.) signals a need to emphasize value-added rental flexibility, rapid replenishment, and bundled disposable kits to win mid-market accounts and clinical sites prioritizing cost control and supply reliability.